Synthesis of optically pure 4-fluoro-glutamines as potential metabolic imaging agents for tumors
- PMID: 21190335
- DOI: 10.1021/ja109203d
Synthesis of optically pure 4-fluoro-glutamines as potential metabolic imaging agents for tumors
Abstract
A versatile synthetic route to prepare all four stereoisomeric 4-fluoro-glutamines was developed by exploiting a Passerini three-component reaction. The skeleton of 4-substituted glutamine derivatives was efficiently constructed. Subsequent four-step reactions, highlighted by a "neutralized" TASF fluorination, provided the desired products with high yields and excellent optical purity. The optically pure fluorine-18 labeled 4-fluoroglutamines were also successfully prepared using either a 18-crown-6/KHCO(3) or K[222]/K(2)CO(3) catalysis system. Preliminary cell uptake and inhibition studies using the 9L tumor cells and SF188(Bcl-xL) tumor cells (a glutamine addicted tumor derived from glioblastoma) provided strong evidence for their potential application in conjunction with positron emission tomography (PET) for in vivo imaging of tumors, which use glutamine as an alternative energy source.
Similar articles
-
Comparative evaluation of 18F-labeled glutamic acid and glutamine as tumor metabolic imaging agents.J Nucl Med. 2012 Oct;53(10):1616-24. doi: 10.2967/jnumed.111.101279. Epub 2012 Aug 30. J Nucl Med. 2012. PMID: 22935578
-
Preparation and characterization of L-[5-11C]-glutamine for metabolic imaging of tumors.J Nucl Med. 2012 Jan;53(1):98-105. doi: 10.2967/jnumed.111.093831. Epub 2011 Dec 15. J Nucl Med. 2012. PMID: 22173839
-
Facile synthesis [5-(13)C-4-(2)H(2)]-L-glutamine for hyperpolarized MRS imaging of cancer cell metabolism.Acad Radiol. 2011 Aug;18(8):932-9. doi: 10.1016/j.acra.2011.05.002. Epub 2011 Jun 11. Acad Radiol. 2011. PMID: 21658976
-
Metabolic Imaging of Glutamine in Cancer.J Nucl Med. 2017 Apr;58(4):533-537. doi: 10.2967/jnumed.116.182345. Epub 2017 Feb 23. J Nucl Med. 2017. PMID: 28232608 Free PMC article. Review.
-
Gamma-fluorinated analogues of glutamic acid and glutamine.Amino Acids. 2003 Apr;24(3):245-61. doi: 10.1007/s00726-002-0410-9. Amino Acids. 2003. PMID: 12707806 Review.
Cited by
-
Non-Invasive Glutamine PET Reflects Pharmacological Inhibition of BRAFV600E In Vivo.Mol Imaging Biol. 2017 Jun;19(3):421-428. doi: 10.1007/s11307-016-1008-z. Mol Imaging Biol. 2017. PMID: 27770401 Free PMC article.
-
Automation of the Radiosynthesis of Six Different 18F-labeled radiotracers on the AllinOne.EJNMMI Radiopharm Chem. 2017;1(1):15. doi: 10.1186/s41181-016-0018-0. Epub 2016 Oct 10. EJNMMI Radiopharm Chem. 2017. PMID: 29564391 Free PMC article.
-
Radiosynthesis and preliminary biological evaluation of N-(2-[18F]fluoropropionyl)-L-glutamine as a PET tracer for tumor imaging.Oncotarget. 2016 Jun 7;7(23):34100-11. doi: 10.18632/oncotarget.9115. Oncotarget. 2016. PMID: 27153544 Free PMC article.
-
Pharmacokinetic Assessment of 18F-(2S,4R)-4-Fluoroglutamine in Patients with Cancer.J Nucl Med. 2020 Mar;61(3):357-366. doi: 10.2967/jnumed.119.229740. Epub 2019 Oct 10. J Nucl Med. 2020. PMID: 31601700 Free PMC article. Clinical Trial.
-
Advances in PET Diagnostics for Guiding Targeted Cancer Therapy and Studying In Vivo Cancer Biology.Curr Pathobiol Rep. 2019 Sep;7(3):97-108. doi: 10.1007/s40139-019-00202-9. Epub 2019 Jul 25. Curr Pathobiol Rep. 2019. PMID: 37092138 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials